Phase II trial of sunitinib for the therapy of progressive metastatic castration-refractory prostate cancer after previous docetaxel chemotherapy. - Sonpavde,G.; Hutson,T.E.; Berry,W.R. (Clin Genitourin Cancer, 2008)